IMODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Imodium, and what generic alternatives are available?
Imodium is a drug marketed by J And J Consumer Inc and Janssen Pharms and is included in eight NDAs.
The generic ingredient in IMODIUM is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Imodium
A generic version of IMODIUM was approved as loperamide hydrochloride; simethicone by PERRIGO R AND D on September 5th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IMODIUM?
- What are the global sales for IMODIUM?
- What is Average Wholesale Price for IMODIUM?
Summary for IMODIUM
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 117 |
Clinical Trials: | 25 |
Patent Applications: | 3,264 |
What excipients (inactive ingredients) are in IMODIUM? | IMODIUM excipients list |
DailyMed Link: | IMODIUM at DailyMed |
Recent Clinical Trials for IMODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Gilead Sciences | Phase 2 |
MedSIR | Phase 2 |
Naia Pharmaceuticals | Phase 1/Phase 2 |
US Patents and Regulatory Information for IMODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J And J Consumer Inc | IMODIUM | loperamide hydrochloride | CAPSULE;ORAL | 017690-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
J And J Consumer Inc | IMODIUM A-D EZ CHEWS | loperamide hydrochloride | TABLET, CHEWABLE;ORAL | 020448-001 | Jul 24, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
J And J Consumer Inc | IMODIUM A-D | loperamide hydrochloride | SOLUTION;ORAL | 019487-001 | Mar 1, 1988 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for IMODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
J And J Consumer Inc | IMODIUM | loperamide hydrochloride | CAPSULE;ORAL | 017694-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Janssen Pharms | IMODIUM | loperamide hydrochloride | SOLUTION;ORAL | 019037-001 | Jul 31, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for IMODIUM
See the table below for patents covering IMODIUM around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
France | 2100711 | ⤷ Sign Up | |
Yugoslavia | 137671 | ⤷ Sign Up | |
Japan | S55120576 | 3*33DIARYLLTETRAHYDROO22FURYLIDENE AMMONIUM SALTS | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for IMODIUM
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0428296 | SPC/GB98/013 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |